SGLT-2 Inhibitors
Top Diabetes Drugs Anticipated To Get Lower Medicare Pricing
Diabetes Drugs Show Promise for Reducing Dementia Risk
Diabetes Challenges, the Search for a Cure, and How to Help
Why Diabetes Miracle Drugs like Ozempic Are Off-Limits to Type 1s
Can You Have DKA Without High Blood Sugars?
Discover the hidden risks of diabetic ketoacidosis (DKA) in insulin-treated diabetes. Learn about euglycemic DKA, triggered by SGLT-2 inhibitors.
Brenzavvy, a Type 2 Diabetes Drug, Available for Less Than $50 Month
New study in Diabetes, Obesity and Metabolism reveals Brenzavvy, an affordable SGLT-2 inhibitor for type 2 diabetes, is heart-safe and effective. It lowers blood sugar and A1C levels, reducing diabetes complications risk.